Sirolimus: A Multi-action Promising Drug

Sirolimus could have a promising role in prophylaxis of rejection, treatment of refractory acute rejection, and chronic allograft dysfunction, as substantiated by various studies. Sirolimus is a new potent immunosuppressant whose profile could offer an advantage over other currently used drugs in view of its absence of intrinsic nephrotoxicity and efficacy as good as cyclosporin. Sirolimus could have both, a steroid sparing as well as a cyclosporin sparing effect.

Sirolimus may have a beneficial role in prophylaxis of rejection as well as treatment of refractory rejection. Sirolimus also has antifungal, antitumor, and anti-smooth muscle proliferative roles. The global sirolimus market was valued at US$ 285.00 Mn in 2018 and is projected to reach US$ 304.08 Mn by 2027, expanding at a CAGR of 1.0% from 2019 to 2027.

Promising Pipeline Opening New Market Opportunities

  • Increase in incidence of target diseases, rise in the number of lifestyle-related disorders, promising pipeline, surge in health care spending, and improvement in health care infrastructure are the factors anticipated to drive the global sirolimus market.
  • Furthermore, increase in preference for generic drug variants and associated side effects are expected to restrain the Sirolimus market.

sirolimus market 3

Global Sirolimus Market: Report Segmentation

  • In terms of application, the global sirolimus market has been categorized into organ transplant rejection, lymphangioleiomyomatosis (LAM), and sirolimus coated balloons & catheter devices.

sirolimus market 2?

  • The organ transplant rejection segment dominated the sirolimus market in 2018 due to rise in the number of organ transplants.
  • Based on distribution channel, the global sirolimus market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies.
  • In terms of region, the global sirolimus market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • North America accounted for major share of the global sirolimus market in 2018. The market in the region is driven by the presence of key players and high rate of adoption of technologies.
    • Additionally, rise in the number of organ transplants is projected to propel the market in North America.
    • Increase in incidence of target diseases, rise in prevalence of lifestyle-related disorders, promising pipeline, and surge in health care spending & improvement in health care infrastructure is anticipated to boost market growth.

Global Sirolimus Market: Competitive Insights

The global sirolimus market is highly fragmented due to the presence of a large number of players. Major players operating in the market include Pfizer, Inc., Biocon, Dr. Reddy’s Laboratories Ltd., Concept Medical, Inc., Stentys SA, Torrent Pharmaceuticals Ltd., Zydus Cadila, and Intas Pharmaceuticals Ltd.

Increase in trend of mergers & acquisitions and product approvals & launches in developing countries is expected to boost the global sirolimus market during the forecast period. Additionally, acquisitions drive growth in core business. Product approvals enable companies to enhance product portfolio globally.

The global sirolimus market has been segmented as follows:

  • Global Sirolimus Market, by Application
    • Organ Transplant Rejection
    • Lymphangioleiomyomatosis (LAM)
    • Sirolimus Coated Balloons & Catheter Devices
  • Global Sirolimus Market, by Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Sirolimus Market, by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

Global Sirolimus Market: Overview

The global sirolimus market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application, distribution channel, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global sirolimus market.

Global Sirolimus Market: Key Segments

  • In terms of application, the global sirolimus market has been segmented into organ transplant rejection, lymphangioleiomyomatosis (LAM), and sirolimus coated balloons & catheter devices.
  • Based on distribution channel, the market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is anticipated to expand at a high CAGR during the forecast period.
  • The market has been analyzed based on price variations, technology trends, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. 

Global Sirolimus Market: Regional Outlook

  • In terms of region, the global sirolimus market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, and Rest of Middle East & Africa).
  • The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in Report

The report also profiles players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the global sirolimus market include Pfizer, Inc., Biocon, Dr. Reddy’s Laboratories Ltd., Concept Medical, Inc., Stentys SA, Torrent Pharmaceuticals Ltd., Zydus Cadila, and Intas Pharmaceuticals Ltd. 

The global Sirolimus market has been segmented as follows:

Global Sirolimus Market, by Application

  • Organ Transplant Rejection
  • Lymphangioleiomyomatosis (LAM)
  • Sirolimus Coated Balloons & Catheter Devices

Global Sirolimus Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Sirolimus Market, by Region

  • North America
    • U.S.
    • Canada 
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe 
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific 
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America 
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa  
.